Reckitt Benckiser Group PLC (RBGLY) - What Are Brokerages Saying About This Stock?

Key Points

• Reckitt Benckiser Group has a “Moderate Buy” consensus rating among 11 covering brokerages, with five buys, two strong buys and four hold ratings.
• Analyst sentiment has been mixed but generally improved: BNP Paribas Exane downgraded the stock to neutral, while Jefferies and Goldman Sachs upgraded it to buy; UBS maintained its buy rating.
• RBGLY opened at $14.56, above its 50-day moving average of $13.90 and near its 200-day average of $14.16. The stock has traded between $12.02 and $17.80 over the past 52 weeks.

Shares of Reckitt Benckiser Group PLC (OTCMKTS:RBGLY - Get Free Report) have earned a consensus rating of "Moderate Buy" from the eleven brokerages that are presently covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating, five have assigned a buy rating and two have issued a strong buy rating on the company.

Several equities analysts have issued reports on the company. BNP Paribas Exane lowered Reckitt Benckiser Group from an "outperform" rating to a "neutral" rating in a research note on Wednesday, September 2nd. Zacks Research upgraded shares of Reckitt Benckiser Group from a "strong sell" rating to a "hold" rating in a report on Friday, August 28th. Jefferies Financial Group upgraded Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research note on Tuesday, July 21st. UBS Group reiterated a "buy" rating on shares of Reckitt Benckiser Group in a research report on Wednesday. Finally, The Goldman Sachs Group upgraded shares of Reckitt Benckiser Group from a "hold" rating to a "buy" rating in a research note on Wednesday, October 7th.

Reckitt Benckiser Group Stock Performance

Reckitt Benckiser Group stock opened at $14.56 on Monday. The company's 50 day moving average price is $13.90 and its two-hundred day moving average price is $14.16. Reckitt Benckiser Group has a 52 week low of $12.02 and a 52 week high of $17.80. The company has a debt-to-equity ratio of 1.31, a current ratio of 0.59 and a quick ratio of 0.40.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc, now operating under the Reckitt name, is a global consumer health and hygiene company headquartered in Slough, England. The company develops, manufactures and markets branded products intended to support personal health, household cleanliness and everyday hygiene.

Its portfolio includes consumer health brands such as Nurofen, Strepsils, Gaviscon, Mucinex and Durex, as well as hygiene and household brands including Dettol, Lysol, Finish and Harpic. Reckitt sells products through pharmacies, supermarkets, mass retailers, e-commerce platforms and other distribution channels.

The company was formed in 1999 through the merger of the British household-products manufacturer Reckitt & Colman and the Dutch company Benckiser.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.